Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...

For the quarter ended December 2024, Amedisys (AMED) reported revenue of $598.05 million, up 4.8% over the same period last year. EPS came in at $0.96, compared to $0.94 in the year-ago quarter. The ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing issued late ...

T he market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by ...

However, UnitedHealth Group and Amedisys allege the lawsuit essentially ignores the companies' proposed divestiture package. The company didn’t identify which locations would be sold ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier. On a ...

On Monday, Raymond (NSE:RYMD) James reaffirmed its Market Perform rating on Amedisys stock, following the company’s fourth-quarter financial results for 2024. Amedisys reported a revenue of $598.1 ...